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Background: The mouse represents an important model system to study the host response to influenza A
infections and to evaluate new prevention or treatment strategies. We and others reported that the susceptibility to
influenza A virus infections strongly varies among different inbred mouse strains. In particular, DBA/2J mice are
highly susceptible to several influenza A subtypes, including human isolates and exhibit severe symptoms after
infection with clinical isolates.
Findings: Upon intra-muscular immunization with live H1N1 influenza A virus (mouse-adapted PR8M, and 2009
pandemic human HA04), DBA/2J mice mounted virus-specific IgG responses and were protected against a
subsequent lethal challenge. The immune response and rescue from death after immunization in DBA/2J was
similar to those observed for C57BL/6J mice.
Conclusions: DBA/2J mice represent a suitable mouse model to evaluate virulence and pathogenicity as well as
immunization regimes against existing and newly emerging human influenza strains without the need for prior
adaptation of the virus to the mouse.
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Influenza A virus infections are a serious health problem,
not only during yearly epidemics but also for newly emer-
ging pandemics [1-4]. The mouse has been shown to rep-
resent a valuable model system to evaluate the virulence
and pathogenicity of presently circulating subtypes as well
as newly emerging H5N1 and 2009 pandemic H1N1 sub-
types (e.g. [5-14]). Bird viruses are able to infect the lungs
of mice without prior adaptation but human isolates differ
largely in their virulence in mice [15,16]. Studies in mice
were initially performed in two inbred mouse strains,
C57BL/6J and BALB/c. We and others demonstrated that
the susceptibility to influenza virus infection largely varies
among different inbred mouse strains [12,15,17-22]. In
particular, DBA/2J mice are highly susceptible to infec-
tions with mouse-adapted viruses. But more importantly,
they support viral replication and develop symptoms upon* Correspondence: klaus.schughart@helmholtz-hzi.de
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reproduction in any medium, provided the orinfection with several human and bird influenza isolates
that were not adapted to the mouse species [15,16,23]. A
total of 18 low-pathogenic non-mouse-adapted influenza
isolates, including five human isolates, were tested in
DBA/2J mice and more than 50% were pathogenic for
DBA/2J whereas only two were pathogenic for C57BL/6J
mice [15]. H3 and H4 subtypes were only low pathogenic
whereas H5, H6, H7, H9, H10 subtypes were highly patho-
genic in DBA/2J mice [15]. Infection of DBA/2J mice with
different H1N1 avian isolates revealed that many were very
virulent in DBA/2J but much less than in BALB/c mice,
and that H2, H3, H4, H6, H10 and H12 subtypes were less
pathogenic than H1N1 subtypes [16].
Thus, DBA/2J mice represent an ideal system to evalu-
ate virulence and pathogenicity but also preventive and
therapeutic interventions against existing and newly
emerging human influenza strains. Here, we demon-
strate that DBA/2J mice immunized intra-muscularly
(i.m.) with live influenza H1N1 viruses developed an
influenza-specific IgG response and were subsequently
protected against lethal infections.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 DBA/2J and C57BL/6J mice mounted influenza-specific
IgG titers after immunization with live PR8M virus. Female
DBA/2J and C57BL/6J mice were immunized by i.m. injection of
2 × 103 FFU PR8M virus in 20 μl PBS. Injections were repeated after
14 days. Sera were taken before immunization (pre-imm) and
14 days after the booster immunization (after boost) by bleeding via
the retro-orbital sinus. Mice were subsequently infected intra-nasally
with 2 × 103 FFU PR8M virus. Sera from surviving DBA/2J and
C57BL/6J mice were collected by heart puncture 14 days after
infection (p.i.). In addition, sera from non-immunized but infected
C57BL/6J mice were collected by heart puncture 14 days after
infection with 2 × 103 FFU PR8M (naïve, p.i.). All sera were diluted
1:1000 and an ELISA for the presence of influenza-specific antibodies
was performed. Absorbance at 405nm is shown. Responses in
DBA/2J mice are indicated in green, responses in C57BL/6J mice in
blue, respectively. Data represent mean values +/- SEM. The
significance of differences between groups was tested using the
Mann-Whitney-U-test, ***: p value < 0.0001.
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at the age of 10-12 weeks by i.m. injection of 2 × 103
focus forming units (FFU) [24] of mouse adapted A/
PuertoRico/8/34 H1N1 virus (PR8M, Münster variant)
in 20μl PBS, and a booster immunization 14 days later
with the same dose of virus. It should be noted that dif-
ferent variants of the laboratory PR8 virus exist which
differ in their virulence in mice [25]. Here, we used the
PR8M (Münster) variant which is lethal for DBA/2J mice
but not for C57BL/6J mice at an infection dose of
2 × 103 FFU [17]. Fourteen days after the boost, mice
were bled via the retro-orbital sinus. All sera were
diluted 1:1000 and an ELISA was performed using plates
that were coated with 1.6 × 105 FFU PR8M virus/ml. For
detection of virus specific IgG, peroxidase-labeled anti-
mouse IgG (KPL; Gaithersburg, Madison, USA) was
used as a secondary antibody and visualization of the re-
action was carried out using a peroxidase specific sub-
strate. As depicted in Figure 1, both DBA/2J and
C57BL/6J mice exhibited significant levels of influenza-
specific IgG levels after immunization compared to naive
mice.
Two weeks after the boost, immunized and non-
immunized DBA/2J mice were challenged by intra-nasal
application with 2 × 103 FFU PR8M virus representing a
55-fold lethal dose [17]. For the infection, mice were
anesthetized by intra-peritoneal injection of a solution
(10μl/g body weight) containing 85% NaCl (0.9%), 10%
Ketamine (100 mg/ml), 5% Xylazine (20 mg/ml). Figure 2
illustrates that body weight loss of immunized DBA/2J
mice was significantly different from non-immunized
DBA/2J mice after infection. Indeed, immunized DBA/2J
mice exhibited only very minor body weight loss after
infection. Whereas all non-immunized DBA/2J mice
succumbed to the infection between day 6 and 7 post in-
fection (p.i.), all immunized mice survived. Furthermore,
C57BL/6J mice were immunized with two i.m. injections
of 2 × 103 FFU PR8M virus, two weeks apart, and subse-
quently infected with 2 × 103 FFU PR8M virus two weeks
after the boost. The infection dose of the challenge is
not lethal for C57BL/6J mice but causes significant body
weight loss [17]. Similarly to DBA/2J mice, immunized
C57BL/6J also exhibited significantly less reduced body
weight loss compared to non-immunized C57BL/6J mice
after infection (Figure 2).
A further increase in the influenza-specific antibody
response was observed in immunized and infected DBA/
2J and C57BL/6J compared to the titers measured after
the booster immunization (Figure 1). The antibody titers
in the immunized and infected C57BL/6J mice were
comparable to non-immunized C57BL/6J mice that sur-
vived the infection (Figure 1).
A single i.m. immunization of DBA/2J mice with
2 × 103 FFU PR8M virus also resulted in an increase ofthe influenza-specific IgG response two weeks later (data
not shown). Although the influenza-specific IgG levels
were lower compared to two immunizations, these mice
were fully protected from a lethal challenge, two weeks
after immunization, with 2 × 103 FFU PR8M virus
(Figure 3).
In addition, we immunized DBA/2J mice by two i.m.
injections (boosting 14 days after the first injection) with
2 × 105 FFU of a human isolate of the pandemic swine
influenza virus A/Hamburg/04/2009 (H1N1, HA04).
Two weeks after the booster immunization, mice were
challenged by intra-nasal application of 2 × 103 FFU
HA04 virus. Non-immunized mice rapidly lost body
weight and died whereas all immunized mice exhibited a
markedly reduced body weight loss and all infected mice
survived (Figure 4).
Here, we demonstrated the proof-of principle for pro-
tective i.m. vaccination in DBA/2J mice using live influ-
enza viruses which is very easy to perform because it
Figure 2 Immunized DBA/2J mice did not lose body weight and survived lethal infection with mouse-adapted H1N1 influenza A virus.
Immunized and naïve female DBA/2J and C57BL/6J mice were infected with 2× 103 FFU/mouse PR8M virus. Body weight loss for each group of
infected mice at various days p.i. (time post infection) is shown with reference to the starting weight (body weight [%]). In addition to mice that
were found dead, mice with a weight loss of more than 30% of the starting body weight were euthanized and recorded as dead. Data represent
mean values +/- SEM. Using the Mann-Whitney-U-test, body weight loss between immunized and naïve DBA/2J mice was significantly different
(p value < 0.05) at day 3 to 6 p.i. Similarly, body weight loss between immunized and naïve C57BL/6J was significantly different at day 5 to 12 p.i.
(p value < 0.05).
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gether with results from other groups [26,27] demon-
strate that DBA/2J represents a very sensitive yet fully
immuno-competent model system which is well suited
to investigate adaptive host immune responses to influ-
enza A virus from bird and human origin without the
need for prior species-adaptation.
However, it should be noted that mouse knock-out
lines are generally created on a C57BL/6N background
[28] and, therefore, the function of a gene in a DBA/2JFigure 3 A single i.m. immunization protects DBA/2J mice from subse
by i.m. injection of 2× 103 FFU PR8M virus (1× i.m.). Immunized and naïve
Body weight loss for each group of mice at various days p.i. (time post infe
[%]). Data represent mean values +/- SEM. Using the Mann-Whitney-U-test,
significantly different at day 5 to 7 p.i. (p < 0.05).knock-out mutant line can only be tested after generat-
ing a congenic line by backcrossing.
Three other studies investigated the host response in
DBA/2J mice after immunization and challenge with
influenza A virus. Boon et al. showed that sera from
humans containing cross-reactive antibodies against pan-
demic H1N1 virus protected DBA/2J mice from an infec-
tion with pandemic H1N1 [15]. Sambhara et al.
immunized DBA/2J mice by subcutaneous injections with
immunostimmulatory complexes containing influenzaquent lethal challenge. Female DBA/2J mice were immunized once
DBA/2J mice were subsequently infected with 2× 103 FFU PR8M virus.
ction) is shown with reference to the starting weight (body weight
body weight loss between immunized and naïve DBA/2J mice was
Figure 4 Immunized DBA/2J mice did not lose body weight
and survived lethal infection with human 2009 pandemic
influenza A virus. Female DBA/2J mice were immunized by i.m.
injection of 2× 105 FFU HA04 virus in 20 μl PBS. Injections were
repeated after 14 days. Immunized and naïve female DBA/2J mice
were infected with 2× 103 FFU HA04 virus. Body weight loss for
each group of infected mice at various days p.i. (time post infection)
is shown with reference to the starting weight (body weight [%]).
In addition to mice that were found dead, mice with a weight loss
of more than 30% of the starting body weight were euthanized and
recorded as dead. Data represent mean values +/- SEM.
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mice are better protected than control groups which were
immunized with a split vaccine that is used in humans
[27]. Solórzano et al., infected the lungs of DBA/2J mice
with live-attenuated influenza virus and demonstrated
that they are protected from lethal infection with pan-
demic human H1N1 virus [26].
In conclusion, our studies demonstrate that DBA/2J
mice are capable of mounting a protective immune re-
sponse against mouse-adapted as well as human isolates
of H1N1 influenza virus. Together with previous studies,
these results endorse the potential of DBA/2J mice as a
highly valuable animal model system to evaluate vaccine
strains and vaccination protocols against human influenza
A virus strains without the need for species-adaptation.
They extend previous studies by demonstrating that also
i.m. injections of live virus are protective and thereby
provide a simple method to evaluate cross-reactivity of
vaccine strains.
Ethics statement
All experiments in mice were approved by an external
committee according to the national guidelines of the
animal welfare law in Germany (‘Tierschutzgesetz in der
Fassung der Bekanntmachung vom 18. Mai 2006 (BGBl.
I S. 1206, 1313), das zuletzt durch Artikel 20 des
Gesetzes vom 9. Dezember 2010 (BGBl. I S. 1934) geän-
dert worden ist.’). The protocol used in these experi-
ments has been reviewed by an ethics committee andapproved by the ‘Niedersächsiches Landesamt für Ver-
braucherschutz und Lebensmittelsicherheit, Oldenburg,
Germany’ (Permit Number: 33.9.42502-04-051/09).
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LD and MM conducted the study, analyzed the results, and contributed to
writing of the manuscript. KS and EW designed the study and wrote the
manuscript. MMB established ELISA assays and contributed to the
manuscript writing. All authors read and approved the final manuscript.
Acknowledgements
This work was supported by intra-mural grants from the Helmholtz-
Association (Program Infection and Immunity) and a research grant
FluResearchNet (No. 01KI07137) from the German Ministry of Education and
Research to KS. MMB has obtained an Alexander-von-Humboldt fellowship.
Mice for these experiments were maintained by the animal caretakers at the
Central Animal Facilities at the HZI. We would like to thank Christin Fricke for
excellent technical assistance. Original stocks of viruses were obtained from
Stefan Ludwig, University of Münster (PR8M) and Thorsten Wolff, Robert-
Koch-Institute, Berlin (HA04).
Received: 29 February 2012 Accepted: 13 September 2012
Published: 19 September 2012
References
1. Fauci AS: Seasonal and pandemic influenza preparedness: science and
countermeasures. J Infect Dis 2006, 194(Suppl 2):S73–S76.
2. Klenk HD, Garten W, Matrosovich M: Molecular mechanisms of
interspecies transmission and pathogenicity of influenza viruses: Lessons
from the 2009 pandemic. Bioessays 2011, 33:180–188.
3. Kilbourne ED: Influenza pandemics of the 20th century. Emerg Infect Dis
2006, 12:9–14.
4. Russell CJ, Webster RG: The genesis of a pandemic influenza virus. Cell
2005, 123:368–371.
5. Matsuoka Y, Lamirande EW, Subbarao K: The mouse model for influenza.
Curr Protoc Microbiol 2009, Chapter 15:Unit 15G 13.
6. Katz JM, Lu X, Tumpey TM, Smith CB, Shaw MW, Subbarao K: Molecular
correlates of influenza A H5N1 virus pathogenesis in mice. J Virol 2000,
74:10807–10810.
7. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, Lien PS, Le QM,
Kawaoka Y: Growth of H5N1 influenza A viruses in the upper respiratory
tracts of mice. PLoS Pathog 2007, 3:1374–1379.
8. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM: A mouse model for
the evaluation of pathogenesis and immunity to influenza A (H5N1)
viruses isolated from humans. J Virol 1999, 73:5903–5911.
9. Maines TR, Lu XH, Erb SM, Edwards L, Guarner J, Greer PW, Nguyen DC,
Szretter KJ, Chen LM, Thawatsupha P, et al: Avian influenza (H5N1) viruses
isolated from humans in Asia in 2004 exhibit increased virulence in
mammals. J Virol 2005, 79:11788–11800.
10. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF,
Palese P, Taubenberger JK, Garcia-Sastre A, et al: Genomic Analysis of
Increased Host Immune and Cell Death Responses Induced by 1918
Influenza Virus. Nature 2006, 443:578–581.
11. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE,
Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM,
Basler CF: Pathogenicity of Influenza Viruses With Genes From the 1918
Pandemic Virus: Functional Roles of Alveolar Macrophages and
Neutrophils in Limiting Virus Replication and Mortality in Mice. J Virol
2005, 79:14933–14944.
12. Trammell RA, Toth LA: Genetic susceptibility and resistance to influenza
infection and disease in humans and mice. Expert Rev Mol Diagn 2008,
8:515–529.
13. Perrone LA, Plowden JK, Garcia-Sastre A, Katz JM, Tumpey TM: H5N1 and
1918 pandemic influenza virus infection results in early and excessive
infiltration of macrophages and neutrophils in the lungs of mice. PLoS
Pathog 2008, 4:e1000115.
Dengler et al. Virology Journal 2012, 9:212 Page 5 of 5
http://www.virologyj.com/content/9/1/21214. Belser JA, Szretter KJ, Katz JM, Tumpey TM: Use of animal models to
understand the pandemic potential of highly pathogenic avian influenza
viruses. Adv Virus Res 2009, 73:55–97.
15. Boon AC, Debeauchamp J, Krauss S, Rubrum A, Webb AD, Webster RG,
McElhaney J, Webby RJ: Cross-reactive neutralizing antibodies directed
against pandemic H1N1 2009 virus are protective in a highly sensitive
DBA/2 influenza mouse model. J Virol 2010, 84(15):7662–7667.
16. Kocer ZA, Krauss S, Stallknecht DE, Rehg JE, Webster RG: The Potential of
Avian H1N1 Influenza A Viruses to Replicate and Cause Disease in
Mammalian Models. PLoS One 2012, 7:e41609.
17. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, Mauel S,
Gruber AD, Schughart K: Host genetic background strongly influences the
response to influenza a virus infections. PLoS One 2009, 4:e4857.
18. Ding M, Lu L, Toth LA: Gene expression in lung and basal forebrain
during influenza infection in mice. Genes Brain Behav 2008, 7:173–183.
19. Boon AC, de Beauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, Finkelstein
D, Neale G, Lu L, Williams RW, Webby RJ: Host genetic variation affects
resistance to infection with a highly pathogenic H5N1 influenza A virus
in mice. J Virol 2009, 83:10417–10426.
20. Otte A, Sauter M, Alleva L, Baumgarte S, Klingel K, Gabriel G: Differential
host determinants contribute to the pathogenesis of 2009 pandemic
H1N1 and human H5N1 influenza A viruses in experimental mouse
models. Am J Pathol 2011, 179:230–239.
21. Boon AC, Finkelstein D, Zheng M, Liao G, Allard J, Klumpp K, Webster R,
Peltz G, Webby RJ: H5N1 Influenza Virus Pathogenesis in Genetically
Diverse Mice Is Mediated at the Level of Viral Load. MBio 2011, 2:. pii:
e00171-00111.
22. Trammell RA, Liberati TA, Toth LA: Host genetic background and the
innate inflammatory response of lung to influenza virus. Microbes Infect
2012, 14(1):50–58.
23. Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, Garcia-Sastre A,
Lowen AC, Palese P, Steel J: The DBA.2 mouse is susceptible to disease
following infection with a broad, but limited, range of influenza A and B
viruses. J Virol 2011, 85(23):12825–12829.
24. Wilk E, Schughart K: The mouse as model system to study host-pathogen
interactions in influenza A infections. Curr Protoc Mouse Biol 2012,
2:177–205.
25. Blazejewska P, Koscinski L, Viegas N, Anhlan D, Ludwig S, Schughart K:
Pathogenicity of different PR8 influenza A virus variants in mice is
determined by both viral and host factors. Virology 2011, 412:36–45.
26. Solorzano A, Ye J, Perez DR: Alternative live-attenuated influenza vaccines
based on modifications in the polymerase genes protect against
epidemic and pandemic flu. J Virol 2010, 84:4587–4596.
27. Sambhara S, Woods S, Arpino R, Kurichh A, Tamane A, Bengtsson KL, Morein
B, Underdown B, Klein M, Burt D: Influenza (H1N1)-ISCOMs enhance
immune responses and protection in aged mice. Mech Ageing Dev 1997,
96:157–169.
28. Brown SD, Moore MW: Towards an encyclopaedia of mammalian gene
function: the International Mouse Phenotyping Consortium. Dis Model
Mech 2012, 5:289–292.
doi:10.1186/1743-422X-9-212
Cite this article as: Dengler et al.: Immunization with live virus vaccine
protects highly susceptible DBA/2J mice from lethal influenza A H1N1
infection. Virology Journal 2012 9:212.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
